CN101850019A - Chinese medicament for treating diabetic acromelic gangrene - Google Patents
Chinese medicament for treating diabetic acromelic gangrene Download PDFInfo
- Publication number
- CN101850019A CN101850019A CN200910236193A CN200910236193A CN101850019A CN 101850019 A CN101850019 A CN 101850019A CN 200910236193 A CN200910236193 A CN 200910236193A CN 200910236193 A CN200910236193 A CN 200910236193A CN 101850019 A CN101850019 A CN 101850019A
- Authority
- CN
- China
- Prior art keywords
- chinese
- parts
- radix
- chinese medicine
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating diabetic acromelic gangrene, and belongs to the field of Chinese medicaments for treating surgical diseases. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as hiraute shiny bugleweed herb, Chinese angelica, radix pseudo-ginseng, Japanese honeysuckle stem, suberect spatholobus stem, glossy ganoderma, snakegourd fruit, radix rehmanniae and the like. The Chinese medicament has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis and relaxing the muscles and removing obstruction in channels, and has the advantages of obvious effect, definite curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment surgery diseases.
Background technology
The Western medicine and the Chinese medicine that are used for the treatment of acromegaly necrosis diabetes at present exist some significantly not enough: the one, and DeGrain, the 2nd, it is slower to take effect, a large amount of patients feel simply helpless in the face of acromegaly necrosis diabetes, suffer from the limb obstinate, constantly worsen, the amputation of being compelled to do is at last handled.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of acromegaly necrosis diabetes, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of acromegaly necrosis diabetes adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
The Herba Lycopi 4---20 parts of 30 parts of Radix Angelicae Sinensis 4---30 portions of Radix Notoginseng 3---
Caulis Lonicerae 5---15 parts of 40 portions of Caulis Spatholobis 4---30 portions of Ganodermas 2---
Fructus Trichosanthis 4---30 parts of Radix Rehmanniae 4--30 part
The Chinese medicine of this treatment acromegaly necrosis diabetes is made by following method:
(1) by above-mentioned weight ratio, Herba Lycopi, Radix Angelicae Sinensis, Caulis Lonicerae, Caulis Spatholobi, Fructus Trichosanthis, the Radix Rehmanniae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We reuse the Herba Lycopi, and the successive dynasties book on Chinese herbal medicine is all put down in writing the merit with blood circulation promoting and blood stasis dispelling, and is Sino-Japan as Shennong's Herbal: " main newborn women interal hemorrhage ... incised wound, carbuncle skin ulcer pus ", modern medicine confirm, the Herba Lycopi has and improves the hemorheology effect preferably; Compatibility can be enriched blood, the Radix Angelicae Sinensis that can invigorate blood circulation, Radix Notoginseng again, and the power of invigorating blood circulation more wins, and the three promotes that mutually the merit of inducing menstruation to relieve menalgia is special; Be aided with Ganoderma, Radix Rehmanniae benefiting QI and nourishing blood, promote the prosperous hemapodium of gas; It is logical that assistant is let out temperature with the Caulis Spatholobi hardship, is victory with the power of invigorating blood circulation, again can channels sootheing and network vessel quickening; The Caulis Lonicerae heat clearing away is stimulated the menstrual flow, and the merit of Fructus Trichosanthis relaxing muscles and tendons and activating QI and blood in the collateral is strong, and relaxing muscles and tendons and activating QI and blood in the collateral is enriched blood in the shared promoting the circulation of blood of three medicines.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of channels sootheing and network vessel quickening pain relieving, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Lycopi's 70 gram Radix Angelicae Sinensis 70 gram Radix Notoginseng 50 grams
Caulis Lonicerae 80 gram Caulis Spatholobis 70 kairine sesames 40 grams
The Fructus Trichosanthis 70 gram Radix Rehmanniae 70 grams
Weight in accordance with regulations, with conventional water extraction process Herba Lycopi, Radix Angelicae Sinensis, Caulis Lonicerae, Caulis Spatholobi, Fructus Trichosanthis, the Radix Rehmanniae are extracted, make extractum fine powder 129 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 782 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Lycopi's 160 gram Radix Angelicae Sinensis 160 gram Radix Notoginseng 110 grams
Caulis Lonicerae 200 gram Caulis Spatholobis 160 kairine sesames 80 grams
The Fructus Trichosanthis 160 gram Radix Rehmanniae 160 grams
By above-mentioned same method, make 1750 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Lycopi's 300 gram Radix Angelicae Sinensis 300 gram Radix Notoginseng 200 grams
Caulis Lonicerae 400 gram Caulis Spatholobis 300 kairine sesames 150 grams
The Fructus Trichosanthis 300 gram Radix Rehmanniae 300 grams
By above-mentioned same method, make 3285 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
5 parts of 6 portions of Radix Notoginseng of 6 parts of Radix Angelicae Sinensis of Herba Lycopi
4 parts of 6 portions of Ganodermas of 6 portions of Caulis Spatholobis of Caulis Lonicerae
6 parts in 6 parts of Radix Rehmanniae of Fructus Trichosanthis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts of 25 portions of Radix Notoginseng of 25 parts of Radix Angelicae Sinensis of Herba Lycopi
10 parts of 25 portions of Ganodermas of 25 portions of Caulis Spatholobis of Caulis Lonicerae
25 parts in 25 parts of Radix Rehmanniae of Fructus Trichosanthis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science acromegaly necrosis diabetes, through 14 routine clinical observations.Selecting the tcm diagnosis acromegaly necrosis diabetes is standard: the diabetics emaciated physique, and limb is soft weak; Suffer from limb and send out cold, poor blood circulation; Amyotrophy; The lower limb weak and faint pulse, intermittent claudication; Legs and feet skin rubefaction, blackout, blue, tissue necrosis; Numb limbs and tense tendons is suffered from the limb acrodynia; Suffer from limb acra ulcer, fester, bleed and suppurate, disunion for a long time.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 8 examples, women's 6 examples do not have other serious disease, and the age is 51 years old-78 years old, 65.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Limbs are warm, send out cool the disappearance; Skin color is progressively bleached (normal skin color) by black purple, and blood circulation obviously improves; Trouble acroanesthesia, acrodynia obviously alleviate; Acra fester alleviation, the healing.
2, effective: body constitution strengthens, and on one's body energetically, limbs are warm, and blood circulation improves; Numb limbs and tense tendons, pain are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, except that hypoglycemic medicine, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.14 philtrums of clinical experiment, produce effects 7 people, effective 6 people, invalid 1 people, total effective rate 92.8%.
Claims (1)
1. a Chinese medicine for the treatment of acromegaly necrosis diabetes adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
The Herba Lycopi 4---20 parts of 30 parts of Radix Angelicae Sinensis 4---30 portions of Radix Notoginseng 3---
Caulis Lonicerae 5---15 parts of 40 portions of Caulis Spatholobis 4---30 portions of Ganodermas 2---
30 parts of Fructus Trichosanthis 4---30 parts of Radix Rehmanniae 4---
The Chinese medicine of this treatment acromegaly necrosis diabetes is made by following method:
(1) by above-mentioned weight ratio, Herba Lycopi, Radix Angelicae Sinensis, Caulis Lonicerae, Caulis Spatholobi, Fructus Trichosanthis, the Radix Rehmanniae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910236193A CN101850019A (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating diabetic acromelic gangrene |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910236193A CN101850019A (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating diabetic acromelic gangrene |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101850019A true CN101850019A (en) | 2010-10-06 |
Family
ID=42801809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910236193A Pending CN101850019A (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating diabetic acromelic gangrene |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101850019A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102631415A (en) * | 2011-03-01 | 2012-08-15 | 四川升和药业股份有限公司 | Traditional Chinese medicine composite as well as product and application thereof |
CN104095178A (en) * | 2013-04-09 | 2014-10-15 | 北京宏泰康达医药科技有限公司 | Composition used for assistant reduction of blood sugar |
CN104840777A (en) * | 2014-02-17 | 2015-08-19 | 贵州百灵企业集团制药股份有限公司 | Diabetes treating traditional Chinese medicine preparation and preparation method thereof |
-
2009
- 2009-10-22 CN CN200910236193A patent/CN101850019A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102631415A (en) * | 2011-03-01 | 2012-08-15 | 四川升和药业股份有限公司 | Traditional Chinese medicine composite as well as product and application thereof |
CN102631415B (en) * | 2011-03-01 | 2015-05-20 | 四川升和药业股份有限公司 | Traditional Chinese medicine composite as well as product and application thereof |
CN104095178A (en) * | 2013-04-09 | 2014-10-15 | 北京宏泰康达医药科技有限公司 | Composition used for assistant reduction of blood sugar |
CN104840777A (en) * | 2014-02-17 | 2015-08-19 | 贵州百灵企业集团制药股份有限公司 | Diabetes treating traditional Chinese medicine preparation and preparation method thereof |
CN104840777B (en) * | 2014-02-17 | 2018-05-15 | 贵州百灵企业集团制药股份有限公司 | A kind of Chinese medicine preparation for treating diabetes and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101390993B (en) | Traditional Chinese medicine for treating diabetic foot | |
CN101850019A (en) | Chinese medicament for treating diabetic acromelic gangrene | |
CN102380063A (en) | Chinese medicament for treating diabetic foot | |
CN102389547A (en) | Traditional Chinese medicine for treating diabetic foot | |
CN101850071A (en) | Chinese medicament for treating chronic nephritis | |
CN102018765A (en) | Traditional Chinese medicine for treating diabetic acromelic gangrene | |
CN101850049B (en) | Chinese medicament for treating diabetic foot | |
CN101843738A (en) | Chinese medicament for treating diabetic feet | |
CN102389544A (en) | Traditional Chinese medicine for treating diabetic foot | |
CN102380065A (en) | Traditional Chinese medicine for treating diabetic feet | |
CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
CN101850018A (en) | Chinese medicament for treating cervical spondylosis | |
CN101564422B (en) | Chinese medicament for treating diabetic gout | |
CN101843871B (en) | Chinese medicament for treating diabetic acro-necrosis | |
CN101843870B (en) | Chinese medicament for treating diabetic acro-necrosis | |
CN101843866A (en) | Chinese medicament for treating diabetic feet | |
CN101843722B (en) | Chinese medicament for treating ichthyosis | |
CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
CN101843711B (en) | Chinese medicament for treating ichthyosis | |
CN101843716B (en) | Chinese medicament for treating femoral head necrosis | |
CN101843864A (en) | Chinese medicament for treating diabetic acro-necrosis | |
CN102380067A (en) | Traditional Chinese medicine for treating diabetic foot | |
CN101850078A (en) | Chinese medicament for treating chronic nephritis | |
CN101879246A (en) | Traditional Chinese medicine for treating lupus erythematosus | |
CN101843737A (en) | Chinese medicament for treating diabetic feet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20101006 |